Alpha Teknova (NASDAQ:TKNO) Releases Earnings Results

Alpha Teknova (NASDAQ:TKNO) announced its earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Trading Up 3.1 %

NASDAQ:TKNO opened at $6.04 on Wednesday. The stock has a market cap of $321.98 million, a price-to-earnings ratio of -8.16 and a beta of 0.34. Alpha Teknova has a one year low of $1.16 and a one year high of $10.37. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73. The business’s 50-day simple moving average is $8.27 and its 200 day simple moving average is $6.89.

Analyst Upgrades and Downgrades

Separately, Craig Hallum assumed coverage on shares of Alpha Teknova in a research note on Monday, February 10th. They issued a “buy” rating and a $12.00 target price for the company.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.